We are live on
!
Find out more
KXA
KPCB XII Associates Portfolio holdings
AUM
$738K
1-Year Est. Return
3.15%
This Fund
S&P 500
This Quarter
Est. Return
-31.62%
1 Year Est. Return
-3.15%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$738K
AUM Growth
-$34.8M
(-98%)
Cap. Flow
-$34.5M
Cap. Flow
% of AUM
-4,674.12%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Inspire Medical Systems
INSP
|
+$34.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 100% |
| 2 | Healthcare | 0% |
Similar funds
TA
LCM
ACP
FG
RCG
FWCM
MVUM
BCIM
KPCB XII Associates's Q3 2020 Portfolio in Review
As of Q3 2020, KPCB XII Associates held 2 positions worth $738K, down 98% from $35.6M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
KPCB XII Associates withdrew a net $34.5M in Q3 2020, closing 1 position. Its most notable exit was Inspire Medical Systems, an estimated $34.5M position sold in full.
By sector, the portfolio is most concentrated in Materials at 100% of assets, up from 3% a quarter earlier, followed by Healthcare.
- KPCB XII Associates fully exited Inspire Medical Systems in Q3 2020, selling an estimated $34.5M.
- KPCB XII Associates's ten largest holdings make up 100% of its $738K portfolio in Q3 2020.
- KPCB XII Associates opened 0 new positions and closed 1 in Q3 2020.
- KPCB XII Associates's portfolio value fell 98% quarter-over-quarter to $738K.
Based on KPCB XII Associates's 13F filing for Q3 2020, filed 20 Oct 2020.